Chapter title |
Strategies for Engineering Protein N-Glycosylation Pathways in Mammalian Cells
|
---|---|
Chapter number | 20 |
Book title |
Glyco-Engineering
|
Published in |
Methods in molecular biology, January 2015
|
DOI | 10.1007/978-1-4939-2760-9_20 |
Pubmed ID | |
Book ISBNs |
978-1-4939-2759-3, 978-1-4939-2760-9
|
Authors |
Qiong Wang, Mark Stuczynski, Yuan Gao, Michael J. Betenbaugh |
Abstract |
Complexity and heterogeneity of oligosaccharides present a considerable challenge to the biopharmaceutical industry to manufacture biotherapeutics with reproducible and consistent glycoform profiles. Mammalian cells, especially Chinese hamster ovary cells, are the most widely used platform for the production of biotherapeutics. The glycans produced are predominantly of the complex type, with some differences between human and nonhuman mammalian glycosylation existing. This review briefly summarizes metabolic glyco-engineering strategies used in mammalian cells in order to alter the glycosylation patterns attached to proteins applied for diverse biotechnology applications. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 1 | 3% |
Unknown | 30 | 97% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 11 | 35% |
Researcher | 4 | 13% |
Student > Master | 3 | 10% |
Student > Bachelor | 2 | 6% |
Unspecified | 1 | 3% |
Other | 2 | 6% |
Unknown | 8 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 8 | 26% |
Chemical Engineering | 5 | 16% |
Agricultural and Biological Sciences | 4 | 13% |
Chemistry | 3 | 10% |
Engineering | 2 | 6% |
Other | 1 | 3% |
Unknown | 8 | 26% |